CA2684368A1 - Secreted frizzled related protein 3 for use in the inhibition of scarring - Google Patents

Secreted frizzled related protein 3 for use in the inhibition of scarring Download PDF

Info

Publication number
CA2684368A1
CA2684368A1 CA002684368A CA2684368A CA2684368A1 CA 2684368 A1 CA2684368 A1 CA 2684368A1 CA 002684368 A CA002684368 A CA 002684368A CA 2684368 A CA2684368 A CA 2684368A CA 2684368 A1 CA2684368 A1 CA 2684368A1
Authority
CA
Canada
Prior art keywords
sfrp3
scarring
therapeutically effective
derivative
wounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002684368A
Other languages
English (en)
French (fr)
Inventor
Mark William James Ferguson
Hugh Laverty
Nicholas Occleston
Sharon O'kane
Kerry Nield
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Renovo Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2684368A1 publication Critical patent/CA2684368A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA002684368A 2007-04-17 2008-04-17 Secreted frizzled related protein 3 for use in the inhibition of scarring Abandoned CA2684368A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0707348.9 2007-04-17
GBGB0707348.9A GB0707348D0 (en) 2007-04-17 2007-04-17 Medicaments and methods for inhibition of scarring
PCT/GB2008/001345 WO2008125869A1 (en) 2007-04-17 2008-04-17 Secreted frizzled related protein 3 for use in the inhibition of scarring

Publications (1)

Publication Number Publication Date
CA2684368A1 true CA2684368A1 (en) 2008-10-23

Family

ID=38116837

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002684368A Abandoned CA2684368A1 (en) 2007-04-17 2008-04-17 Secreted frizzled related protein 3 for use in the inhibition of scarring

Country Status (7)

Country Link
US (1) US20100261659A1 (enExample)
EP (1) EP2148726A1 (enExample)
JP (1) JP2010524910A (enExample)
AU (1) AU2008237751A1 (enExample)
CA (1) CA2684368A1 (enExample)
GB (1) GB0707348D0 (enExample)
WO (1) WO2008125869A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8725477B2 (en) 2008-04-10 2014-05-13 Schlumberger Technology Corporation Method to generate numerical pseudocores using borehole images, digital rock samples, and multi-point statistics
WO2009126888A2 (en) 2008-04-10 2009-10-15 Services Petroliers Schlumberger Method for characterizing a geological formation traversed by a borehole
US8311788B2 (en) 2009-07-01 2012-11-13 Schlumberger Technology Corporation Method to quantify discrete pore shapes, volumes, and surface areas using confocal profilometry
KR102022116B1 (ko) 2011-06-24 2019-09-18 노노 인코포레이티드 허혈에 대한 psd-95 억제제와의 조합 요법
US9241970B2 (en) * 2011-12-13 2016-01-26 Nono Inc. Therapy for subarachnoid hemorrhage and ischemia

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7049291B2 (en) * 1996-10-11 2006-05-23 The United States Of America As Represented By The Department Of Health And Human Services Isolation and method of using tissue growth-inducing Frzb protein
EP1012262A4 (en) * 1997-08-12 2002-11-06 Human Genome Sciences Inc HFLP PROTEIN HFLP
EP1639097B1 (en) * 2003-06-25 2013-08-07 Ottawa Health Research Institute Methods and compositions for modulating stem cell growth and differentiation
WO2005070448A2 (en) * 2004-01-21 2005-08-04 Five Prime Therapeutics, Inc. Methods of use for secreted frizzled-related protein 3 (sfrp-3) in the prevention and treatment of disease
US7638128B2 (en) * 2005-08-19 2009-12-29 The Brigham And Women's Hospital, Inc. Method of enhancing cardiac tissue repair by administering a SFRP polypeptide

Also Published As

Publication number Publication date
AU2008237751A1 (en) 2008-10-23
JP2010524910A (ja) 2010-07-22
WO2008125869A1 (en) 2008-10-23
GB0707348D0 (en) 2007-05-23
EP2148726A1 (en) 2010-02-03
US20100261659A1 (en) 2010-10-14

Similar Documents

Publication Publication Date Title
US20120238505A1 (en) Medicaments
US20100266532A1 (en) Methods for inhibiting scarring
WO2008078099A1 (en) Lxr- antagonists for the prevention, reduction or inhibition of scarring
US20100261659A1 (en) Secreted frizzled related protein 3 for use in the inhibition of scarring
US20110212897A1 (en) Wnt3a for inhibition of scarring
US20100144690A1 (en) Medicaments and methods for promoting wound contraction
US20100137201A1 (en) Medicaments
US20110082171A1 (en) Medicaments and Methods for Inhibition of Scarring
JP2010535184A (ja) 非眼瘢痕の抑制に使用できる薬剤および方法
HK1105366B (en) Il-10 related peptides for wound healing

Legal Events

Date Code Title Description
FZDE Dead

Effective date: 20130417